Open AccessReconstruction options and outcomes for breast sarcoma patients
Author(s) -
Carl Hannah M.,
Calotta Nicholas A.,
Siotos Charalampos,
Bos Tobias J.,
Foster Dennis G.,
Manahan Michele A.,
Cooney Carisa M.,
Sacks Justin M.,
Rosson Gedge D.
Publication year - 2019
Publication title -
the breast journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.533
H-Index - 72
eISSN - 1524-4741
pISSN - 1075-122X
DOI - 10.1111/tbj.13243
Subject(s) - medicine , breast reconstruction , sarcoma , implant , breast cancer , surgery , mastectomy , mammaplasty , population , cancer , radiology , pathology , environmental health
Breast sarcomas constitute a rare and heterogeneous group of tumors. Given their aggressive nature and the potential for extensive resections, rates of reconstruction have been low. We retrospectively reviewed subjects derived from our institutional registry presented between 2003 and 2015. Thirty‐four patients with primary breast sarcoma were identified. The average age was 51.9 years and the average follow‐up was 58 months. The most common histological type was malignant phyllodes (61.8%). Two patients suffered cancer recurrence. Twelve patients (35.3%) underwent reconstruction. Four underwent implant‐based reconstruction, seven had autologous‐based reconstruction, and one had combined reconstruction. Major complications were one flap loss and one implant removal. Our relatively high rates of breast reconstruction suggest a newly increased willingness to offer reconstruction to this rarer patient population.